Active surveillance for nonmuscle invasive bladder cancer

Active surveillance for nonmuscle invasive bladder cancer

Nonmuscle invasive bladder cancer (NMIBC) is known to be a heterogeneous malignancy that requires varying treatment modalities and follow-up schedules. Low-grade Ta papillary tumors are categorized as low-risk NMIBC because of their favorable prognosis. There is an expanding movement that overdiag...

Full description

Bibliographic Details
Main Authors:	Makito Miyake, Kiyohide Fujimoto, Yoshihiko Hirao
Format:	Article
Language:	English
Published:	Korean Urological Association 2016-06-01
Series:	Investigative and Clinical Urology
Subjects:	Local neoplasm recurrence; Risk assessment; Urinary bladder neoplasms; Watchful waiting
Online Access:	https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-S4.pdf

Similar Items

Can tumor recurrence be reduced with plasma-kinetic vaporization of the area around the tumor in nonmuscle invasive bladder cancer?
by: Yüksel Yılmaz, et al.
Published: (2018-07-01)

A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer
by: Bellat, V., et al.
Published: (2022)

Diagnostics techniques in nonmuscle invasive bladder cancer
by: Ayman Soubra, et al.
Published: (2015-01-01)

Current status of active surveillance in prostate cancer
by: Mun Su Chung, et al.
Published: (2016-01-01)

Super active surveillance for low-risk prostate cancer | Opinion: No
by: Saum Ghodoussipour, et al.

Super active surveillance for low-risk prostate cancer | Opinion: Yes
by: Leonardo O. Reis, et al.

Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era
by: Mun Su Chung, et al.
Published: (2021-07-01)

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
by: Sang Hun Song, et al.
Published: (2021-01-01)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
by: Wan Song, et al.
Published: (2019-11-01)

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
by: Jungyo Suh, et al.
Published: (2021-07-01)

Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse
by: Fabio Zattoni, et al.

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
by: Min Ji Jeon, et al.
Published: (2021-08-01)

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
by: Byung Soo Kim, et al.
Published: (2018-01-01)

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
by: Chang Wook Jeong, et al.
Published: (2014-12-01)

Dietary factors associated with bladder cancer
by: Chandrika Piyathilake
Published: (2016-06-01)

A Case of Extravesical Metastases Occurring after Transurethral Resection of Non-Invasive Bladder Cancer
by: Ga Ram Kang, et al.
Published: (2018-02-01)

Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
by: Haci Ibrahim Cimen, et al.

Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma
by: Jack Barnett, et al.
Published: (2021-01-01)

Demographic and Survivorship Disparities in Non–muscle-invasive Bladder Cancer in the United States
by: Munseok Seo, et al.
Published: (2018-09-01)

Solitary Bladder Metastasis of Prostate Cancer Mimicking Bladder Submucosal Tumor: A Case Report
by: Doo Ri Kim, et al.
Published: (2017-09-01)

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up
by: Ji Yong Ha, et al.
Published: (2017-05-01)

Molecular aspects of bladder cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2011-03-01)

Concurrent Testicular and Bladder Cancer in a 57-year-old Man
by: Esther Han, et al.
Published: (2015-09-01)

Glycosaminoglycans in the urinary bladder mucosa, tumor tissue and mucosal tissue around tumor
by: Bojanić Nebojša, et al.
Published: (2012-01-01)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
by: Coleman McFerrin, et al.
Published: (2020-11-01)

Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review
by: Daher C. Chade, et al.
Published: (2009-12-01)

Non-occupational risk factors for bladder cancer
by: Luiz Alexandre Villares da Costa, et al.
Published: (2008-12-01)

Allelotyping and promoter hypermethylation of urinary bladder cancer.
Published: (2002)

Invasive bladder cancer in the eighties: transurethral resection or cystectomy?
by: Oscar Rodriguez Faba, et al.
Published: (2011-02-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Nishanth Krishnananthan, et al.
Published: (2016-06-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Henk G. van der Poel, et al.
Published: (2016-06-01)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
by: Filipe LF. Carvalho, et al.
Published: (2020-07-01)

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin
by: Milošević Radovan, et al.
Published: (2015-01-01)

Current topics on prostate and bladder pathology
by: Daniel Abensur Athanazio, et al.
Published: (2018-10-01)

Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
by: Marco Racioppi, et al.

MRI should be routine for all patients with localized prostate cancer? | Opinion: No
by: Joel B. Nelson

Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer
by: Rajan Veeratterapillay, et al.
Published: (2021-09-01)

MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes
by: Ronaldo Hueb Baroni

Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study
by: Vincenzo Favilla, et al.

Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
by: Turgay Turan, et al.